BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 8057303)

  • 1. Reduction of the hepatic radioactivity levels of [
    Suzuki H; Matsukawa M; Madokoro R; Terasaka Y; Kannaka K; Uehara T
    Nucl Med Biol; 2024; 132-133():108910. PubMed ID: 38636351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of human sarcoma with radiolabeled monoclonal antibody. A preliminary study.
    Greager JA; Brown JM; Pavel DG; Garcia JL; Blend M; Das Gupta TK
    Cancer Immunol Immunother; 1986; 23(2):148-54. PubMed ID: 3779715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal Radioiodinated Ferulic Acid Polymeric Micelles as the First Nuclear Medicine Imaging Probe for ETRA Brain Receptor.
    Fayez H; Selim AA; Shamma RN; Rashed HM
    Curr Radiopharm; 2024 Jan; ():. PubMed ID: 38213167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DMSO increases radioiodination yield of radiopharmaceuticals.
    Wang K; Adelstein SJ; Kassis AI
    Appl Radiat Isot; 2008 Jan; 66(1):50-9. PubMed ID: 17931872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodination and biodistribution of newly synthesized 3-benzyl-2-([3-methoxybenzyl]thio)benzo[
    Al-Salahi R; Moustapha ME; Abuelizz HA; Alharthi AI; Alburikan KA; Ibrahim IT; Marzouk M; Motaleb MA
    Saudi Pharm J; 2018 Dec; 26(8):1120-1126. PubMed ID: 30532632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Next Generation ADO (NGA) - Zusammenschluss des dermatoonkologischen Nachwuchses].
    Schaper-Gerhardt K; Kött J
    J Dtsch Dermatol Ges; 2023 Dec; 21(12):1580-1581. PubMed ID: 38082526
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation and Evaluation of Thermosensitive Liposomes Encapsulating I-125-Labeled Doxorubicin Derivatives for Auger Electron Therapy.
    Elghobary MEN; Munekane M; Mishiro K; Fuchigami T; Ogawa K
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-Specific Radioiodination of Oligonucleotides with a Phenolic Element in a Programmable Approach.
    Zhao H; Qin Y; Liu D; Geng X; Wang C; Ding D; Ding X; Xia Q; Liu J; Wang R; Tan W
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent.
    Feng Y; Zhou Z; McDougald D; Meshaw RL; Vaidyanathan G; Zalutsky MR
    Nucl Med Biol; 2021 Jan; 92():171-183. PubMed ID: 32448731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor outcome with anti-programmed death-ligand 1 (PD-L1) antibody due to poor pharmacokinetic properties in PD-1/PD-L1 blockade-sensitive mouse models.
    Kurino T; Matsuda R; Terui A; Suzuki H; Kokubo T; Uehara T; Arano Y; Hisaka A; Hatakeyama H
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32041818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine-123 labelled radiopharmaceuticals and single-photon emission tomography: a natural liaison.
    Bourguignon MH; Pauwels EK; Loc'h C; Mazière B
    Eur J Nucl Med; 1997 Mar; 24(3):331-44. PubMed ID: 9143474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
    Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
    J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
    Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
    Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of a metabolizable ester bond in radioimmunoconjugates.
    Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Design of radiolabeled antibody fragments for tumor-selective radioactivity localization--brush border enzyme-sensitive bond to decrease renal accumulation of radioactivity].
    Mukai T; Fujioka Y; Arano Y; Saji H
    Yakugaku Zasshi; 2003 Aug; 123(8):647-52. PubMed ID: 12931660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
    Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
    J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
    Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
    Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.